Form 4: Outset Medical EVP Sells Shares for Tax Obligations

Outset Medical's EVP of Operations R&D & Service, Marc Nash, sold 108 shares of common stock to cover tax withholding obligations related to vested performance share units.

Summary

• Marc Nash, Executive Vice President of Operations R&D & Service at Outset Medical, Inc. (OM), reported a transaction on January 7, 2026.
• Nash disposed of 108 shares of Outset Medical Common Stock at a price of $4.27 per share.
• This sale was a 'sell to cover' transaction, executed to satisfy tax withholding obligations.
• The tax obligations were incurred in connection with the vesting of 289 shares of Common Stock underlying Performance Share Units (PSUs).
• These PSUs were earned based on performance criteria achieved as of December 31, 2024, or January 6, 2025, and certified by the Issuer's Compensation Committee on January 17, 2025.
• The PSUs vested and were released on January 6, 2025.
• Following this reported transaction, Marc Nash directly beneficially owns 48,160 shares of Outset Medical Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary 'sell to cover' for tax obligations related to vested equity, which is a routine event and does not reflect a change in management's sentiment or the company's operational performance. Therefore, it is neutral.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation and tax obligations, which is common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in insider sentiment or company fundamentals.
• Employees: The vesting of Performance Share Units (PSUs) indicates that performance criteria were met, which could be seen positively by employees as a validation of company performance.

Key Dates

Keywords

Outset Medical, OM, Insider Transaction, Form 4, Marc Nash, Stock Sale, Sell to Cover, Performance Share Units, Equity Compensation, Tax Withholding